| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 06/06/2002 | WO2002043716A2 Method for regulating prostate gland volume with insulin sensitizers |
| 06/06/2002 | WO2002043666A2 Compositions containing an antioxidant such as alpha lipoic acid, carnitine, vitamin c or vitamin e for preventing or inhibiting loss of cognitive function |
| 06/06/2002 | WO2002043662A2 Dietary composition containing conjugated linoleic acid and calcium for improved health |
| 06/06/2002 | WO2002043661A2 Recombinant anti-cd30 antibodies and uses thereof |
| 06/06/2002 | WO2002043659A2 Composition containing statins and calcium for improved cardiovascular health |
| 06/06/2002 | WO2002043652A2 Anti-proliferative drugs |
| 06/06/2002 | WO2002043507A2 Nutrient supplements and methods for treating autism and for preventing the onset of autism |
| 06/06/2002 | WO2002028895A3 Cyclic peptides, method for preparing same and use as angiogenesis inhibitor or activator |
| 06/06/2002 | WO2002024148A3 Method or treatment of tumors using transforming growth factor-alpha |
| 06/06/2002 | WO2002024144A3 Use of transcription factors for treating inflammation and other diseases |
| 06/06/2002 | WO2002020435A3 Generation of combinatorial libraries and assessment thereof by deconvolution |
| 06/06/2002 | WO2002015809A3 Dental composition for hypersensitive teeth |
| 06/06/2002 | WO2002014448A3 Adhesive blends comprising hydrophilic and hydrophobic pressure sensitive adhesives |
| 06/06/2002 | WO2002011551A3 Oil/fat composition |
| 06/06/2002 | WO2002005843A3 Human rrp sequences and methods of use |
| 06/06/2002 | WO2001096557A3 A human homologue of the dbf4/ask1 protein, nucleic acids, and methods related to the same |
| 06/06/2002 | WO2001094414A3 THE HUMAN VOLTAGE GATED SODIUM CHANNEL β-1A SUBUNIT AND METHODS OF USE |
| 06/06/2002 | WO2001094293A3 Benzamide ligands for the thyroid receptor |
| 06/06/2002 | WO2001090360A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/06/2002 | WO2001090334A3 Drug metabolizing enzymes |
| 06/06/2002 | WO2001080860A3 Daily treatment for erectile dysfunction using a pde5 inhibitor |
| 06/06/2002 | WO2001074768A3 Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease |
| 06/06/2002 | WO2001072323A3 Use of insulin for the treatment of cartilagenous disorders |
| 06/06/2002 | WO2001068098A3 Cephalotaxine alkaloid combination compositions and uses thereof |
| 06/06/2002 | WO2001064907A3 Lipid metabolism enzymes |
| 06/06/2002 | WO2001048209B1 Genes identified as required for proliferation of e. coli |
| 06/06/2002 | WO2001045727A3 Stabilized veterinary compositions comprising more than one antiviral agent |
| 06/06/2002 | WO2001012168A3 Antiviral pharmaceutical compositions containing iron chelators |
| 06/06/2002 | WO2001003684A3 Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies |
| 06/06/2002 | WO2000065346A9 Diagnosis of human kidney diseases |
| 06/06/2002 | US20020069424 Protein-protein interactions in neurodegenerative disorders |
| 06/06/2002 | US20020068825 Polypeptide for use in the treatment of nervous system disorders |
| 06/06/2002 | US20020068761 Administering a therapeutically effective amount of a neutral 3:1 gallium complex of a 3- hydroxy-4-pyrone derivative to a patient infected by a prokaryote of geneus mycobacterium |
| 06/06/2002 | US20020068757 Administering biflavanoid selected from robustaflavone, amentoflavone, agathisflavone, volkensiflavone, rhusflavanone, succedaneaflavanone, morelloflavone etc. and atleast one antiviral agent to treat viral infection |
| 06/06/2002 | US20020068754 Combination of adrenergic agonist and aryl-cyclo-alkanolamine for relieving chronic pain without adverse side effects |
| 06/06/2002 | US20020068747 Inhibitors of prenyl-protein transferase |
| 06/06/2002 | US20020068746 Pyrrolo[2,3-d]pyrimidine compounds |
| 06/06/2002 | US20020068743 Composition comprising camptothecin and a pyrimidine derivative for the treatment of cancer |
| 06/06/2002 | US20020068740 Treatment of diabetic complications such as diabetic neuropathy, diabetic nephropathy, diabetic retinopathy, myocardial infarction, cataracts and diabetic cardiomyopathy. |
| 06/06/2002 | US20020068737 Antagonists for human alpha 1a receptors; lowering intraocular pressure; inhibiting cholesterol synthesis; relaxing lower urinary tract tissue; treatment of benign prostatic hyperplasia, impotency, cardiac arrhythmia, etc. |
| 06/06/2002 | US20020068732 Combination of a 5-HT2C receptor agonist and a 5-HT6 receptor antagonist, or a salt, enantiomer or prodrug form |
| 06/06/2002 | US20020068728 Composition to boost libido |
| 06/06/2002 | US20020068719 Synergy between low molecular weight heparin and platelet aggregation inhibitors, providing a combination therapy for the prevention and treatment of various thromboembolic disorders |
| 06/06/2002 | US20020068692 Administration a melatonin blocker to patients with disorders associated with altered dopamine function; preclinical diagnosis by administering melatonin to induce a mild transient form of the disorder |
| 06/06/2002 | US20020068341 Human kallikrein |
| 06/06/2002 | US20020068323 Nucleotide sequences which code polypeptide for use in human therapeutics ad diagnostics |
| 06/06/2002 | US20020068313 Methods of diagnosing and treating crohn's disease using pseudomonas antigens |
| 06/06/2002 | US20020068278 Protein for use as antitumor agent; for use as antimetastsis agent |
| 06/06/2002 | US20020068273 Mimetics and inhibitors of the interaction between Vpr (HIV vIral protein of regulation) and ANT (mitochondrial adenine nucleotide translocator) |
| 06/06/2002 | US20020068092 Stabilizers prevent aggregation of nanoparticles and increase bioadhesion to substrates such as an insect, teeth, bone, nails, chitin, feathers, scales, mucous, skin, hair, and/or plant tissue |
| 06/06/2002 | US20020068089 Comprises biocompatible hydrophilic cationic microparticles and cell adhesion promoter implanted into the lower esophageal sphincter |
| 06/06/2002 | US20020068079 Solution containing ethylenediaminetetraacetic acid-complex and sodium selenite for livestock feeds; provided on stick for livestock animals to lick |
| 06/06/2002 | US20020068071 Enhancement of the cellular immune response |
| 06/06/2002 | US20020068069 spsA polynucleotides and polypeptides |
| 06/06/2002 | US20020068065 Pharmaceutical composition having specific water activity |
| 06/06/2002 | US20020068062 Inhibitors of the formation of soluble human CD23 |
| 06/06/2002 | US20020067798 Methods and devices for quantitative analysis of x-ray images |
| 06/06/2002 | DE10058596A1 Verfahren zum Screening von chemischen Verbindungen zur Modulierung der Wechselwirkung einer EVH1-Domäne oder eines Proteins mit einer EVH1-Domäne mit einer EVH1-Bindedomäne oder einem Protein mit einer EVH1-Bindedomäne sowie ein Verfahren zum Nachweis besagter Wechselwirkung Method for screening chemical compounds for modulating the interaction of an EVH1 domain or a protein having an EVH1 domain with an EVH1-binding domain or a protein having an EVH1-binding domain and a method for the detection of said interaction |
| 06/06/2002 | DE10057290A1 Enteral zu verabreichendes Supplement zur parenteralen Ernährung oder partiellen enteralen/oralen Ernährung bei kritisch Kranken, chronisch Kranken und Mangelernährten To be administered enterally supplement for parenteral nutrition or partial enteral / oral nutrition in critically ill patients, chronically ill and malnourished |
| 06/06/2002 | CA2791831A1 Rna interference mediating small rna molecules |
| 06/06/2002 | CA2436941A1 Novel human nucleic acid molecules and polypeptides encoding a novel human ion channel expressed in spinal cord and brain |
| 06/06/2002 | CA2431837A1 Method for diagnosing a tumor in a patient determining the concentration of pibf |
| 06/06/2002 | CA2430924A1 Angiotensin receptor antagonist composition for the treatment of sexual dysfunction associated with hypertension and another condition |
| 06/06/2002 | CA2430625A1 A virus which can express tumor angiostatin factor with high efficiency in specific tumor cells and the use of it |
| 06/06/2002 | CA2430485A1 Cytonkine receptor zcytor19 |
| 06/06/2002 | CA2430473A1 Diagnosis and treatment of disease |
| 06/06/2002 | CA2430401A1 Uses of mammalian genes and related reagents |
| 06/06/2002 | CA2430341A1 Genetically engineered herpes virus for the treatment of cardiovascular disease |
| 06/06/2002 | CA2430309A1 Combination of gaba agonists and aldose reductase inhibitors |
| 06/06/2002 | CA2430298A1 Combination of gaba agonists and sorbitol dehydrogenase inhibitors |
| 06/06/2002 | CA2430296A1 Anti-proliferative drugs |
| 06/06/2002 | CA2430199A1 Use of(-) (3-halomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia |
| 06/06/2002 | CA2430087A1 Photochemical internalization for delivery of molecules into the cytosol |
| 06/06/2002 | CA2430082A1 Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379 |
| 06/06/2002 | CA2429814A1 Rna interference mediating small rna molecules |
| 06/06/2002 | CA2429801A1 Behavior chemotherapy |
| 06/06/2002 | CA2429722A1 Expression analysis of fkbp nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 06/06/2002 | CA2429721A1 Expression analysis of inhibitor of differentiation nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 06/06/2002 | CA2429599A1 Use of b7rp1 antagonists in ige-mediated disorders |
| 06/06/2002 | CA2429382A1 Indole-type inhibitors of p38 kinase |
| 06/06/2002 | CA2428595A1 Staphylococcus aureus protein staau_r2, gene encoding it and uses thereof |
| 06/06/2002 | CA2427681A1 Dietary composition containing conjugated linoleic acid and calcium for improved health |
| 06/06/2002 | CA2427618A1 Composition containing statins and calcium for improved cardiovascular health |
| 06/06/2002 | CA2427470A1 Compositions containing an antioxidant such as alpha lipoic acid, carnitine, vitamin c or vitamin e for preventing or inhibiting loss of cognitive function |
| 06/06/2002 | CA2427098A1 1-(2-m-methanesulfonamidophenylethyl)-4-(m-trifluoromethylphenyl)piperazine and pharmaceutically acceptable salts and solvates thereof and their use in the treatment of incontinence |
| 06/05/2002 | EP1211313A2 Modulation of PDE11A activity |
| 06/05/2002 | EP1210951A2 Combination for treating andropause containing estrogen agonists/antagonists and testosterone |
| 06/05/2002 | EP1210950A1 Composition against Coccidiosis |
| 06/05/2002 | EP1210940A2 Antifatigue composition |
| 06/05/2002 | EP1210939A2 Pharmaceutical compositions comprising paracetamol and L-Cysteine or a precursor thereof |
| 06/05/2002 | EP1210937A2 Device for topical treatment of acne and its method of manufacture |
| 06/05/2002 | EP1210605A2 Analysis and treatment of body weight and eating disorders |
| 06/05/2002 | EP1210463A2 Polymorphisms in the human cyp3a4 and cyp3a7 genes and their use in diagnostic and therapeutic applications |
| 06/05/2002 | EP1210462A2 Polymorphisms in the human hpxr gene and their use in diagnostic and therapeutic applications |
| 06/05/2002 | EP1210455A1 Novel glycosyl sulfotransferases gst-4 alpha, gst-4 beta, and gst-6 |
| 06/05/2002 | EP1210453A2 Hdac4 and hdac5 in the regulation of cardiac gene expression |
| 06/05/2002 | EP1210447A2 Adenoviral vectors having nucleic acids encoding immunomodulatory molecules |
| 06/05/2002 | EP1210435A1 Fhm, A NOVEL MEMBER OF THE TNF LIGAND SUPERGENE FAMILY |
| 06/05/2002 | EP1210434A2 Mammalian interleukin-12 p40 and interleukin b30. combinations thereof. antibodies. uses in pharmaceutical compositions |
| 06/05/2002 | EP1210429A2 Apoptosis proteins |